BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/14/2020 1:45:26 PM | Browse: 1007 | Download: 1246
 |
Received |
|
2020-01-24 17:03 |
|
Peer-Review Started |
|
2020-01-24 17:04 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-02-27 03:57 |
|
Revised |
|
2020-03-27 01:57 |
|
Second Decision |
|
2020-05-27 06:19 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-05-28 03:01 |
|
Articles in Press |
|
2020-05-28 03:01 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-06-12 08:53 |
|
Publish the Manuscript Online |
|
2020-06-14 13:45 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Ever-increasing diversity of drug-induced pancreatitis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Simcha Weissman, Muhammad Aziz, Ryan B Perumpail, Tej I Mehta, Rutwik Patel and James H Tabibian |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
James H Tabibian, FACP, MD, PhD, Associate Professor, Division of Gastroenterology, Department of Medicine, Olive View-UCLA Medical Center, 14445 Olive View Dr., 2B-182, Sylmar, CA 91342, United States. jtabibian@dhs.lacounty.gov |
| Key Words |
Drug-induced pancreatitis; Acute pancreatitis; Pharmacology; Mechanism of action; Inflammation; Etiology |
| Core Tip |
Despite living in an era of pharmacologic expansion, our knowledge of drug-induced pancreatitis (DIP) is often curtailed by evidence needed to implicate particular medications. Several causative agent classification systems (with medication lists) have been reported and their mechanisms proposed. Nonetheless, they require regular updates and a complete review of this topic is warranted. In addition, infrequently prescribed medications or those available over-the-counter are often omitted from those summarized lists. We review the ever-increasing diversity of DIP and their potential mechanisms of injury to aid in increasing both primary and secondary prevention of DIP. |
| Publish Date |
2020-06-14 13:45 |
| Citation |
Weissman S, Aziz M, Perumpail RB, Mehta TI, Patel R, Tabibian JH. Ever-increasing diversity of drug-induced pancreatitis. World J Gastroenterol 2020; 26(22): 2902-2915 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i22/2902.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i22.2902 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
